Top Scoops

Book Reviews | Gordon Campbell | Scoop News | Wellington Scoop | Community Scoop | Search


The Detail: How Big Pharma operates in New Zealand

From The Detail, 5:00 am today

Nanoparticles (yellow) targeting and entering cancer cells (blue Photo: Wikimedia Commons

Cancer has become a political football. Funding of drugs, treatments, and heartbreaking stories of sufferers have many questioning the role of the country’s unique drug-funding agency Pharmac.

Listen to the podcast here. duration 22:11

Click a link to play audio (or right-click to download) in either
MP3 format or in OGG format.

Patients are resorting to Givealittle pages to raise the money they need for unfunded drugs. Experimental but hopeful-sounding treatments are being denied.’s Laura Walters has been looking at what’s behind this explosion of victim stories.

“There’s a bit more behind it,” she says. “Not all of these campaigns and all of these stories - but some of them - are being pushed by Big Pharma. And that sounds a bit foreign – usually when we talk about Big Pharma we’re talking about the United States. But actually these massive multi-national pharmaceutical companies operate arms in New Zealand as well.”

We’re talking the big names you know: GlaxoSmithKline, Pfizer, Merck Sharpe & Dohme. “I guess you could call them all-star players when it comes to the game of how they want to get their drugs funded,” she says.

Their aims are aligned with the aims of patients. Big Pharma want their drugs bought; patients want the drugs their doctors have told them will give them the best chance. Both sides are willing to push their stories out there to create pressure to either fast-track a drug, or help Pharmac change its mind about an application for drugs funding.

Walters says the drug companies are playing in an emotional space, and they know how to get what they want. Often the best way to do that is keep their own faces out of the public eye.

“They set up these campaigns, and they make sure they push out those heart-warming stories in order to create awareness in the public of people that are suffering, but also to build that momentum of calls for these drugs to be funded.

“So what might look like a single story of someone who desperately needs this new cancer drug to help them live a few months longer and spend a bit more time with their family, on the face of it might just look like a human interest story. But actually there are all these other interests behind it, these agendas of Big Pharma that are pushing it. Not all the time – but quite frequently. I don’t think most of the public recognise who’s behind some of these stories and who’s really, really pushing some of these campaigns.”

In New Zealand a lot of that work is done via the main pharmaceutical lobby group Medicines NZ.

Coming up to the 2017 election it spent about $150,000 on something described in its financial reports as ‘Election 2017 project’. It’s not clear what the project was.

Walters says the group was incredibly cagey about it when asked about it. “That’s one of the issues here – there’s not a lot of transparency,” she says. “But what we do know was, that at the time there was a lot of push for an interim drugs fund – access to new and emerging medicines, and a fund to be set up for that.”

In The Detail today Walters talks to Alex Ashton about how Big Pharma lobbying in New Zealand works, and why Pharmac’s unique funding system is a target.

Made possible by the RNZ/NZ on Air Innovation Fund
Photo: RNZ

© Scoop Media

Top Scoops Headlines


Gordon Campbell: On Coronavirus, And The Iowa Debacle

As Bloomberg says, the coronavirus shutdown is creating the world’s biggest work-from-home experiment. On the upside, the mortality rate with the current outbreak is lower than with SARS in 2003, but (for a number of reasons) the economic impact this time ... More>>

Gordon Campbell: On Dodging A Bullet Over The Transport Cost Over-Runs

As New Zealand gears up to begin its $6.8 billion programme of large scale roading projects all around the country, we should be aware of this morning’s sobering headlines from New South Wales, where the cost overruns on major transport projects ... More>>

Gordon Campbell:On Kobemania, Palestine And The Infrastructure Package

Quick quiz to end the week. What deserves the more attention – the death of a US basketball legend, or the end of Palestinian hopes for an independent state? Both died this week, but only one was met with almost total indifference by the global community. More>>

Gordon Campbell: On The Double Standard That’s Bound To Dominate The Election

Are National really better political managers than Labour, particularly when it comes to running the economy? For many voters – and the business community in particular - their belief in National’s inherent competence is a simple act of faith. More>>

Gordon Campbell : On Dealing With Impeccable, Impeachable Lies

By now, the end game the Republican Senate majority has in mind in their setting of the rules for the impeachment trial of Donald J. Trump is pretty clear to everyone: first deny the Democrats the ability to call witnesses and offer evidence, and then derisively dismiss the charges for lack of evidence. For his part, does former security adviser John Bolton really, really want to testify against his former boss? If there was any competing faction within the Republican Party, there might be some point for Bolton in doing so – but there isn’t. More>>

Gordon Campbell: On Why The Dice Are Loaded Against Women In Public Life

If they enter public life, women can expect a type of intense (and contradictory) scrutiny that is rarely applied to their male counterparts... More>>

Gordon Campbell: On The Harry/Meghan Affair, And Iran

Those “Meghzit” headlines seem apt, given how closely Britain’s January 31 exit from the European Union resembles the imminent departure from the Royal Family’s top team of Prince Harry and Meghan Markle. For young Iranians, the accidental downing of the Ukrainian airliner is just the latest example of the deadly incompetence and dishonesty of their leaders... More>>